Adequacy of Haemodiafiltration: Middle Molecules Clearance, Patients Reported Outcomes and Sodium Balance
Recruiting now
Conditions studied: Haemodiafiltration, Haemodialysis, Patient Reported Outcome Measurements, Nutrition, Malnutrition (Calorie), Fluid Balance Outcomes
In brief
The goal of this observational study is to understand the differences in terms of middle molecules clearance and patient outcomes in High (\>23Litres (L)) vs Low (\<23 L) convection volume (CV) Hemodiafiltration (HDF) and to understand the effect of dialysate fluid sodium concentration (137 vs 140 mmol/L) on overhydration volume in patients on HD and HDF.
Key facts
- Study ID
- NCT07717255
- Run by
- East and North Hertfordshire NHS Trust
- People needed
- 300
- Starts
- 2025-01-09
- Expected to finish
- 2030-11-01
- Last updated by the study team
- 2026-07-21
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 18 years or above.
- Ability to give informed consent.
- End stage kidney disease (ESKD) treated by haemodialysis for at least 3 months.
- Prognosis > 6 months as assessed by principal investigator (PI)
Where it is running
- Lister Hospital, East and North Hertfordshire NHS Trust — Stevenage, Hertfordshire, United Kingdom (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.